financetom
Business
financetom
/
Business
/
Northwestern Energy Group Insider Sold Shares Worth $384,430, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Northwestern Energy Group Insider Sold Shares Worth $384,430, According to a Recent SEC Filing
Dec 13, 2024 1:33 PM

04:07 PM EST, 12/13/2024 (MT Newswires) -- Anthony Thomas Clark, Director, on December 12, 2024, sold 7,400 shares in Northwestern Energy Group ( NWE ) for $384,430. Following the Form 4 filing with the SEC, Clark has control over a total of 16,816 shares of the company, with 16,816 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1993004/000199300424000118/xslF345X05/wk-form4_1734123847.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ingredion Q3 Adjusted Earnings, Net Sales Decrease; 2025 Outlook Lowered - Shares Down Pre-Bell
Ingredion Q3 Adjusted Earnings, Net Sales Decrease; 2025 Outlook Lowered - Shares Down Pre-Bell
Nov 4, 2025
06:44 AM EST, 11/04/2025 (MT Newswires) -- Ingredion ( INGR ) reported Q3 adjusted earnings Tuesday of $2.75 per diluted share, down from $3.05 a year earlier. Analysts polled by FactSet expected $2.88. Net sales for the quarter ended Sept. 30 were $1.82 billion, down from $1.87 billion a year earlier. Analysts surveyed by FactSet expected $1.89 billion. For 2025,...
Kura Oncology Q3 net loss widens to $74.1 mln
Kura Oncology Q3 net loss widens to $74.1 mln
Nov 4, 2025
Overview * Kura Oncology reports Q3 2025 net loss of $74.1 mln, up from $54.4 mln in 2024 * Collaboration revenue for Q3 2025 was $20.8 mln, compared to none in Q3 2024 * Company's ziftomenib program under FDA Priority Review, PDUFA date set for Nov 30, 2025 Outlook * Kura Oncology ( KURA ) expects FDA decision on ziftomenib...
MPLX Q3 Adjusted Earnings, Revenue Rise
MPLX Q3 Adjusted Earnings, Revenue Rise
Nov 4, 2025
06:44 AM EST, 11/04/2025 (MT Newswires) -- MPLX ( MPLX ) reported Q3 adjusted earnings Tuesday of $1.52 per diluted share, up from $1.01 a year earlier. Four analysts polled by FactSet expected $1.08. Revenue for the quarter ended Sept. 30 was $3.62 billion, compared with $2.97 billion a year earlier. Four analysts surveyed by FactSet expected $3.16 billion. ...
Molson Coors Q3 profit misses estimates on goodwill impairment charge
Molson Coors Q3 profit misses estimates on goodwill impairment charge
Nov 4, 2025
Overview * Molson Coors ( TAP/A ) Q3 net sales fell 2.3%, missing analyst expectations * Adjusted EPS for Q3 decreased 7.2%, missing consensus estimates * Company reported a $3.65 bln goodwill impairment charge, impacting net income Outlook * Company expects 2025 net sales to decline 3% to 4% in constant currency * Molson Coors ( TAP/A ) sees 2025...
Copyright 2023-2026 - www.financetom.com All Rights Reserved